Total Payments
$8,938
2024 Payments
$222.79
Companies
35
Transactions
403
Medicare Patients
2,461
Medicare Billing
$841,397
Payment Breakdown by Category
Food & Beverage$8,154 (91.2%)
Consulting$750.00 (8.4%)
Education$34.84 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,154 | 399 | 91.2% |
| Consulting Fee | $750.00 | 1 | 8.4% |
| Education | $34.84 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,225 | 111 | $0 (2024) |
| Janssen Biotech, Inc. | $1,326 | 40 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $749.08 | 50 | $0 (2024) |
| Gilead Sciences, Inc. | $527.28 | 22 | $0 (2023) |
| Celgene Corporation | $502.92 | 37 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $475.09 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $337.12 | 18 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $310.79 | 3 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $265.49 | 13 | $0 (2023) |
| Braintree Laboratories, Inc. | $203.56 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $222.79 | 5 | Enterra Medical, Inc. ($145.37) |
| 2023 | $1,427 | 72 | ABBVIE INC. ($271.22) |
| 2022 | $1,425 | 64 | ABBVIE INC. ($378.74) |
| 2021 | $1,778 | 87 | AbbVie Inc. ($568.06) |
| 2020 | $383.65 | 22 | AbbVie Inc. ($139.66) |
| 2019 | $580.74 | 28 | AbbVie, Inc. ($194.44) |
| 2018 | $1,177 | 60 | AbbVie, Inc. ($330.03) |
| 2017 | $1,945 | 65 | Janssen Biotech, Inc. ($952.82) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Gastroenterology | ||||||
| 06/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/15/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $145.37 | General |
| 02/08/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/14/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology | ||||||
| 12/07/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology | ||||||
| 12/05/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.33 | General |
| Category: Neuroscience | ||||||
| 12/04/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $0.31 | General |
| Category: Neuroscience | ||||||
| 12/01/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.10 | General |
| 11/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.06 | General |
| Category: Neuroscience | ||||||
| 11/14/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/10/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Immunology | ||||||
| 11/07/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/06/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: GI | ||||||
| 11/02/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/02/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Neuroscience | ||||||
| 11/01/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 10/12/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 344 | 381 | $174,444 | $44,224 |
| 2022 | 12 | 408 | 4,038 | $382,360 | $107,197 |
| 2021 | 17 | 912 | 41,622 | $2.1M | $612,901 |
| 2020 | 17 | 797 | 884 | $519,165 | $77,074 |
Total Patients
2,461
Total Services
46,925
Medicare Billing
$841,397
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $40,474 | $12,134 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 114 | $30,894 | $11,213 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 50 | 50 | $13,450 | $4,081 | 30.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $32,909 | $4,000 | 12.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $16,785 | $3,371 | 20.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $10,803 | $2,537 | 23.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $9,163 | $2,154 | 23.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $11,715 | $1,916 | 16.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $5,820 | $1,845 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,431 | $972.66 | 40.0% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 12 | 3,600 | $187,200 | $60,542 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $26,654 | $12,244 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 97 | $18,785 | $8,927 | 47.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 21 | 21 | $23,502 | $4,405 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $28,841 | $4,164 | 14.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 49 | 49 | $8,266 | $3,889 | 47.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $41,793 | $3,533 | 8.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $15,424 | $2,889 | 18.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $11,299 | $2,202 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 28 | $3,746 | $1,911 | 51.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 13 | 13 | $13,000 | $1,496 | 11.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 15 | 35 | $3,850 | $995.47 | 25.9% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2021 | 36 | 28,500 | $1.5M | $481,472 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 127 | 181 | $62,988 | $18,453 | 29.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 138 | 202 | $69,488 | $17,600 | 25.3% |
About Dr. Maria Hatara, MD
Dr. Maria Hatara, MD is a Gastroenterology healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427217439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Hatara, MD has received a total of $8,938 in payments from pharmaceutical and medical device companies, with $222.79 received in 2024. These payments were reported across 403 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,154).
As a Medicare-enrolled provider, Hatara has provided services to 2,461 Medicare beneficiaries, totaling 46,925 services with total Medicare billing of $841,397. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Huntersville, NC
- Active Since 06/04/2008
- Last Updated 09/24/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427217439
Products in Payments
- STELARA (Biological) $1,496
- ZEPOSIA (Drug) $953.63
- XIFAXAN (Drug) $648.69
- CREON (Drug) $335.89
- Mavyret (Drug) $288.20
- MAVYRET (Drug) $285.06
- RINVOQ (Biological) $282.64
- Humira (Biological) $266.59
- LINZESS (Drug) $232.22
- Entyvio (Biological) $209.91
- INTERSTIM (Device) $203.06
- CLENPIQ (Drug) $172.73
- HUMIRA (Biological) $161.41
- OCALIVA (Drug) $149.25
- Creon (Drug) $146.05
- VIBERZI (Drug) $144.69
- REMICADE (Biological) $141.64
- Cimzia (Drug) $135.05
- ENTYVIO (Biological) $119.40
- SUPREP (Drug) $119.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntersville
Sharad Nangia, M.d, M.D
Gastroenterology — Payments: $954.45
Gastroenterology $954.45
Dr. Scott Brotze, M.d, M.D
Gastroenterology — Payments: $930.52
Gastroenterology $930.52
Caroline Barrett, M.d, M.D
Gastroenterology — Payments: $728.64
Gastroenterology $728.64
Dr. Devi Thangavelu, M.d, M.D
Gastroenterology — Payments: $693.27
Gastroenterology $693.27
Dr. Steven Josephson, M.d, M.D
Gastroenterology — Payments: $670.16
Gastroenterology $670.16
Rebecca Rawl, Md, MD
Gastroenterology — Payments: $594.06
Gastroenterology $594.06